Safety in mind as Prescient Therapeutics develops next-generation CAR-T platform
Tragedy struck the CAR-T space this month with a US company halting a trial of...
Tragedy struck the CAR-T space this month with a US company halting a trial of...
In a milestone development regarding its innovative CAR-T cancer therapy programs, Prescient Therapeutics Limited (ASX:PTX) has announced...
Clinical stage oncology company Prescient Therapeutics (ASX:PTX) has announced another crucial step forward in the development of...
Prescient Therapeutics (PTX) has slipped on the ASX today despite announcing some key developments for...
The terrible news this week that Tmunity Therapeutics, a clinical stage biotherapeutics company, has halted...
Australia’s medical community has welcomed a new ‘patent box’ tax regime designed to encourage further...
he federal government’s “patent box” initiative caught the eye of Australia’s biotech sector in Tuesday...
Prescient Therapeutics (ASX:PTX) has announced a new research program with the Peter MacCallum Cancer Centre...
Prescient Therapeutics Ltd (ASX:PTX) has signed an agreement related to advancing a new research program with...
Prescient Therapeutics (PTX) has announced a new research program with the Peter MacCallum Cancer Centre...
This investor centre was built by Reach Markets
©2022 Reach Markets
To stay up to date with Prescient Therapeutics news and events, please register your details.